MedPath

CKD-341

Generic Name
CKD-341

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects

Phase 1
Completed
Conditions
Hypertension
Interventions
First Posted Date
2022-10-07
Last Posted Date
2023-03-22
Lead Sponsor
Chong Kun Dang Pharmaceutical
Target Recruit Count
30
Registration Number
NCT05571813
Locations
🇰🇷

Central Hospital, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath